Medical ABS Trolley Patient Treatment Carts

Name: Medical ABS Trolley Patient Treatment Carts
Brand: Guangzhou Shileva Medical Equipment Co., Ltd.
SKU: 845125205

Guangdong, ChinaGuangzhou Shileva Medical Equipment Co., Ltd.

US$280.00-290.00

1 Piece

Sample price:US$290.00/piece.Request sample

Product profile

Customization

Available

Material

ABS

Wheel Type

Swivel Casters

Model NO.

SLV-85001A

Type

Nursing Cart

Feature

Easy Cleaning, Corrosion Resistance

Color

Blue

Customized

Condition

New

Business Type

Manufacturer

Trolley Diamension

850*520*950mm

Top Board

ABS

Columns

Aluminum/Plastic-Steel

Option 1

Disposable Lock

Option 2

Stainless Steel Plate

Option 3

Storage Box

Option 4

Dust Basket with Foot Pedal

Option 5

Suction Pump Shell

Option 6

Big Basket Can Load 4L Needle Disposal Holder

Transport Package

Standard Carton

Specification

850*520*950mm

Trademark

Shileva

Origin

China

HS Code

94029000

Production Capacity

40, 000pieces/Year

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export ExperienceSelf-branded

Guangzhou Shileva Medical Equipment Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available CertifiedCustomization Options: Flexible customization CertifiedExport Year: 13 Years CertifiedNearest Port: Shenzhen Port, Guangzhou PortAverage Response Time: ≤2.38h

AI-Powered supplier vetting

SummaryThe supplier is a limited company with 13 employees, a 3,200 m² manufacturing plant, six production lines, and stated annual output of 40,000 hospital or medical bed sets. It offers medical beds, hospital trolleys, and medical furniture, with exports representing 51%–70% of sales and markets in South America, Africa, Southeast Asia, and the Middle East. Production lead time is within 15 working days off-season and one month during peak season. The supplier reports R&D activity, new products in the past year, and ODM capability. Quality assurance, corrective-action, preventive-action, and complaint-handling procedures are documented with records. However, no valid manufacturing-capacity contract with associated subcontractors, overseas warehouse, overseas showroom, overseas agents or branches, or offline trade-show participation is reported. Certification holdings, customer cases, and financial credibility cannot be sufficiently assessed from the provided information.

Supplier typeThe supplier is identified as a combined company and a limited company, operates independently without an indicated larger company group, and offers medical beds, hospital trolleys, and medical furniture. Its business scope is therefore clearly manufacturing and supplying medical-related products, although the records do not fully clarify the meaning of the 'combined' classification.

After-Sales capabilityThe supplier has in-stock service capacity and documented procedures and records for customer complaints, corrective actions, and preventive actions. However, it has no overseas warehouse, showroom, overseas agent or branch, and reports services in zero countries, so its overseas after-sales coverage is limited.

R&D capabilityThe supplier reports new products within the past year and provides ODM services, which directly supports active product-development capability. It does not have an available SDK and does not provide OEM services for popular brands, but those limitations do not negate the stated R&D and ODM capabilities.

Production capacityThe supplier reports six production lines, a 3,200 m² plant, 13 employees, and annual hospital or medical bed output of 40,000 sets. Lead time is within 15 working days off-season and one month during peak season, while the absence of a valid manufacturing-capacity contract with associated subcontractors represents a documented capacity-governance weakness.

Customization capabilityODM service is explicitly available, and the supplier offers multiple medical-product categories including beds, trolleys, carts, cabinets, stretchers, and mattresses. The slices do not specify customization scope, engineering resources, minimum quantities, or execution examples, so the evidence supports ODM availability but not the full depth of customization capability.